Biolegend, 421403, FOXP3 Fix/Perm Buffer Set, 100tests

BioLegend's FOXP3 Fix/Perm Buffer Set has been specially formulated for intracellular staining FOXP3 with minimum effect on the surface fluorochrome staining. It contains one 30 ml 4X concentrated FOXP3 Fix/Perm buffer (Cat. No. 421401) and one 25 mL 10X concentrated FOXP3 Perm buffer (Cat. No. 421402). The FOXP3 Fix/Perm buffer (4X) must be freshly diluted to 1X working solution with PBS (10 mM sodium phosphate, 150 mM sodium chloride, pH 7.2) prior to staining procedures. e.g. Dilute one (1) part FOXP3 Fix/Perm buffer (4X) to three (3) parts PBS. The FOXP3 Perm buffer (10X) should be diluted to 1X working solution with PBS (10 mM sodium phosphate, 150 mM sodium chloride, pH 7.2) prior to staining procedures. e.g. Dilute one (1) part FOXP3 Perm buffer(10X) to nine (9) parts PBS. Warning: The FOXP3 Buffer Set can have a deleterious effect on tandem fluorophores (particularly APC/Cyanine7) in a multicolor assay, causing an increase in compensation into the APC channel. If your panel contains a surface stain with an antibody conjugated to a tandem fluorophore, consider using the True-Nuclear™ Transcription Factor Buffer Set (Cat. No. 424401) instead, which provides a clearer resolution of FoxP3 as well as other nuclear transcription factors. Please refer to the data provided here. Caution: The FOXP3 Fix/Perm buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contact.
100tests
Storage & Handling: Store between 2°C and 8°C. Do not freeze.To obtain lot-specific expiration date, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.) This product has a shelf-life of 12 months or less. Please contact our technical support team for lot specific CoA and expiration date inquiries of this product.
Application: ICFC - Quality tested
Recommended Usage: The FOXP3 Fix/Perm Buffer (4x) must be diluted to a 1X working solution with PBS prior to staining procedures. Dilute 1 part FOXP3 Fix/Perm Buffer (4x) to 3 parts PBS (10 mM sodium phosphate, 150 mM sodium chloride, pH 7.2). The FOXP3 Perm Buffer (10x) must be diluted to a 1X working solution with PBS prior to staining procedures. Dilute 1 part FOXP3 Perm Buffer (10x) to 9 parts PBS. NOTE: FOXP3 Perm Buffer (10x) may exhibit crystallization or precipitation when stored at 2-8°. This is normal and does not affect the buffer's performance. Heavy precipitation observed after dilution to a 1x solution can be cleared by filtration.
Application Notes: NOTE: For flow cytometric staining, True-Nuclear™ Transcription Factor Buffer Set (Cat. No. 424401) offers improved staining and is highly recommended over the Foxp3 Fix/Perm Buffer Set (Cat. No. 421403). FOXP3 Intracellular Staining Procedure Perform cell surface staining as described in Cell Surface Immunofluorescence Staining Protocol. Prepare a 1x working solution of FOXP3 Fix/Perm Buffer by diluting 1 part FOXP3 Fix/Perm Buffer (4x) (Cat. No. 421401) in 3 parts PBS (10 mM sodium phosphate, 150 mM sodium chloride, pH 7.2). Add 1 ml of 1X FOXP3 Fix/Perm solution to each sample. Vortex and incubate at room temperature in the dark for 20 minutes. Spin at 250 x g for 5 minutes and discard the supernatant. (Optional stopping point) Resuspend cells in 1 mL of Cyto-Last™ Buffer (recommended) (Cat. No. 422501) or Cell Staining Buffer (Cat. No. 420201) and store at 4°C. When ready to continue, centrifuge at 250 × g for 5 minutes. Discard the supernatant and proceed to the next step. Prepare a 1x working solution of FOXP3 Perm Buffer by diluting 1 part FOXP3 Perm Buffer (10x) (Cat. No. 421402) to 9 parts PBS (10 mM sodium phosphate, 150 mM sodium chloride, pH 7.2). NOTE: FOXP3 Perm Buffer (10x) may exhibit crystallization or precipitation when stored at 2-8°. This is normal and does not affect the buffer's performance. Heavy precipitation observed after dilution to a 1x solution can be cleared by filtration. Wash once with 1 ml of 1X FOXP3 Perm Buffer. Resuspend cells in 1 ml of 1X FOXP3 Perm Buffer, incubate at room temperature in the dark for 15 minutes. Spin down cells and discard the supernatant, then resuspend the pellet in 100 μL of 1X FOXP3 Perm Buffer. Add an appropriate amount of fluorochrome-conjugated anti-FOXP3 antibody and incubate at room temperature in the dark for 30 minutes. Wash twice with Cell Staining Buffer, and resuspend in 0.5 ml of Cell Staining Buffer, then analyze with a flow cytometer.
Application References(PubMed link indicates BioLegend citation): Yang ZZ, et al. 2006. Blood 107:3639. PubMed Groh V, et al. 2006. Nat. Immunol. 7:755. PubMed Bamias G, et al. 2007. J. Immunol. 178:1809. PubMed MacDonald K PA, et al. 2007. Blood doi:10.1182/blood-2007-01-067249. PubMed Müller M, et al. 2007. J. Immunol. 179:2774. Dang Y,et al.2007.Clin Cancer Res.13:1883. PubMed Basu S, et al. 2008. J. Immunol. 180:5974. PubMed Takamura S, et al. 2010. J. Immunol. 184:4696. PubMed Beavis, PA., et al. 2011. PNAS. 108:16717. PubMed Kling J, et al. 2013. Exp Parasitol. 129:270. PubMed Troutman TD, et al. 2012. PNAS. 109:273. PubMed Faustman DL, et al. 2012. PLoS One. 7:e41756. PubMed Liu Y, et al. 2012. Food Chem Toxicol. 50:1920. PubMed Kawamoto N, et al. 2013. Int Immunol. 25:53. PubMed Morandi B, et al. 2013. J. Immunol. 191:4858. PubMed Shiba T, et al. 2014. Toxicol Appl Pharmacol. 274:191. PubMed Cook KW, et al. 2014. Gut. PubMed Shibuya KC, et al. 2014. PLoS One. 9:96565. PubMed Cecil DL, et al. 2014. Cancer Res. 74:2710. PubMed Linnerbauer S, et al. 2014. PLoS Pathog. 10:1004068. PubMed Basu S, et al. 2015. J Leukoc Biol. 97:279. PubMed
Product Citations: Shibuya K, et al. 2014. PLoS One. 9:96565. PubMed Williams JW, et al. 2020. Nat Immunol. 1194:21. PubMed Danileviciute E, et al. 2022. Nat Metab. 4:589. PubMed Freimer JW, et al. 2022. Nat Genet. 54:1133. PubMed Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed Fetit R, et al. 2023. Development. 150:. PubMed Jin J, et al. 2023. Nat Aging. 3:600. PubMed Chiu H, et al. 2021. iScience. 24:102748. PubMed Vella JL, et al. 2021. Life Sci Alliance. 4:. PubMed Jin J, et al. 2021. Sci Immunol. 6:. PubMed Hippen KL, et al. 2021. Cytotherapy. 23:704. PubMed Ren J, et al. 2022. Proc Natl Acad Sci U S A. 119:e2117401119. PubMed Guttman O, et al. 2022. J Cell Biol. 221: . PubMed Wang Z, et al. 2022. Proc Natl Acad Sci U S A. 119:e2201899119. PubMed Zhou Y, et al. 2022. Evid Based Complement Alternat Med. 2022:2197763. PubMed Hajjar S, et al. 2022. Cell Death Differ. 29:585. PubMed Yang D, et al. 2016. PLoS Negl Trop Dis. 10: 0004335. PubMed Singh AK, et al. 2017. JCI Insight. 2:e94275. PubMed Zbinden A, et al. 2021. Adv Sci (Weinh). 2002500:8. PubMed Mizraji G, et al. 2017. Cell Rep. 18(2):419-431. PubMed Puc I, et al. 2022. Int J Mol Sci. 23:. PubMed Song J, et al. 2022. Clin Transl Med. 12:e992. PubMed Zemek RM, et al. 2020. Nat Protoc. 15:1628. PubMed Troutman T, et al. 2012. Proc Natl Acad Sci U S A. 109:273. PubMed Kawamoto N, et al. 2013. Int Immunol. 25:53. PubMed Kamigaki T, et al. 2015. Anticancer Res. 35: 4535-4543. PubMed Fernandez SV, et al. 2020. Breast Cancer Res. 1.009722222. PubMed Cook K, et al. 2014. Gut. . PubMed Bamias G, et al. 2007. J Immunol. 178:1809. PubMed Dang Y, et al. 2007. Clin Cancer Res . 1.932638889. PubMed Yang Z, et al. 2006. Blood. 107:3639. PubMed Morandi B, et al. 2013. J Immunol. 191:4858. PubMed Satoh M, et al. 2016. Sci Rep. 6:28473. PubMed Zhao XY, et al. 2020. Sci Adv. 6:eaay6191. PubMed Bankoti R, et al. 2017. Sci Rep. 10.1038/s41598-017-12171-3. PubMed Basu S, et al. 2015. J Leukoc Biol. 97:279. PubMed Haller M, et al. 2016. Diabetes. 65(12):3765-3775. PubMed Van Gool F, et al. 2019. Immunity. 50:362. PubMed Takamura S, et al. 2010. J Immunol. 184:4696. PubMed Brennan CA, et al. 2021. Gut Microbes. 13:1987780. PubMed Scur M, et al. 2022. Nat Commun. 13:7272. PubMed Greaney SK, et al. 2020. Cancer Immunol Res. 0.504166667. PubMed Matisz C, et al. 2017. Sci Rep. 7:40631. PubMed Pfirrmann V, et al. 2015. Cytotherapy. 17: 1139-1151. PubMed Cecil D, et al. 2014. Cancer Res. 74:2710. PubMed Liu Y, et al. 2012. Food Chem Toxicol. 50:1920. PubMed Beavis P, et al. 2011. Proc Natl Acad Sci U S A. 108:16717. PubMed Zhou Q, et al. 2015. J Immunol. 195: 2493-250. PubMed Huang S, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.75. PubMed Basu S, et al. 2008. J Immunol. 180:5794. PubMed Luo G, et al. 2021. Sci Rep. 11:7841. PubMed Keefe RC, et al. 2021. Sci Rep. 11:14933. PubMed Kwek S, et al. 2015. Cancer Immunol Res. 3: 1008-1016. PubMed Shiba T, et al. 2014. Toxicol Appl Pharmacol. 274:191. PubMed de Winde CM, et al. 2021. J Cell Sci. 134: . PubMed Li H, et al. 2015. Reproduction. 150: 417-427. PubMed Andersen K, et al. 2017. J Am Soc Nephrol. 28:76. PubMed Oliveira G, et al. 2015. Sci Transl Med. 7: 317ra198. PubMed Urueña C, et al. 2022. Front Med (Lausanne). 9:991873. PubMed Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed Chiaro J, et al. 2021. Cancer Immunol Res. 9:981. PubMed Solleiro-Villavicencio H, et al. 2015. Clin Immunol. . PubMed Martini E, et al. 2016. Cell Rep. 14:1062-1073. PubMed Jacobs H, et al. 2016. J Immunol. 196: 3525 - 3531. PubMed MacDonald K, et al. 2007. Blood . 109:5049. PubMed Méndez-Lagares G, et al. 2021. J Clin Invest. 131:e148542. PubMed Mishra P, et al. 2016. PLoS Negl Trop Dis. 10: 0004787. PubMed Weber A, et al. 2016. Infect Immun . 84: 1413 - 1423. PubMed Linnerbauer S, et al. 2014. PLoS Pathog. 10:1004068. PubMed Zheng D, et al. 2022. Front Immunol. 13:808347. PubMed Kling J, et al. 2011. Exp Parasitol. 129:270. PubMed Okagawa T, et al. 2016. Infect Immun . 84: 77 - 89. PubMed Namas R, et al. 2016. Lupus Sci Med. 3: e000148. PubMed Javed A, et al. 2015. PLoS One. 10: 0142086. PubMed Li Y, et al. 2015. J Immunol. 195: 1591 - 1598. PubMed Faustman D, et al. 2012. PLoS One. 7:e41756. PubMed Alizadeh A, et al. 2018. J Neuroinflammation. 15:53. PubMed Okano T, et al. 2017. Sci Rep. 7:42412. PubMed Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
Cell Type: Tregs
Biology Area: Immunology, Transcription Factors
Molecular Family: Nuclear Markers
Gene ID: NA
Regulatory Status: RUO
Other Names: FOXP3 Fixation/Permeabilization Buffer
Q: Can I stain whole blood with anti-FOXP3 using your Foxp3 staining kit?
A: It is not recommended. It is best to use PBMCs for this testing.
Q: Can FOXP3 be costained with cytokines?
A: The larger holes created by the nuclear permeabilization required for FOXP3 may allow cytokines to leak out of the cell, making it harder to detect lowly-expressed cytokines. You may have to use a control where the cells are only permeabilized through the cell membrane.